MicroRNAs in human lung cancer

Experimental Biology and Medicine

Volumn 239, Issue 11, 2014, Pages 1505-1513

  Kang, Sung Min ^a   Lee, Heon Jin ^a  

^a Kyungpook National University   (South Korea)

Author keywords

cancer biomarkers; lung cancer; MicroRNA; NKX2 1; serum microRNA

Indexed keywords

BIOLOGICAL MARKER; HIGH MOBILITY GROUP A PROTEIN; MICRORNA; ONCOPROTEIN; RNA POLYMERASE II; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ARTICLE; BIOGENESIS; CANCER DIAGNOSIS; CANCER PROGNOSIS; CELL MIGRATION; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; LUNG CANCER; MOLECULAR GENETICS; PATHOGENESIS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MOLECULAR PATHOLOGY; PATHOLOGY;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LUNG NEOPLASMS; MICRORNAS; PATHOLOGY, MOLECULAR;

EID: 84910029844     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214533887     Document Type: Article

References (126)

1. Bartel DP.MicroRNAs: genomics, biogenesis, mechanism, and function.Cell. 2004;116:281-97
2. Bushati N,Cohen SM.microRNA functions.Annu Rev Cell Dev Biol. 2007;23:175-205
3. Kim VN.MicroRNA precursors in motion: exportin-5 mediates their nuclear export.Trends Cell Biol. 2004;14:156-9
4. Lund E,Guttinger S,Calado A,Dahlberg JE,Kutay U.Nuclear export of microRNA precursors.Science. 2004;303:95-8
5. Yi R,Doehle BP,Qin Y,Macara IG,Cullen BR.Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs.RNA. 2005;11:220-6
6. Bohnsack MT,Czaplinski K,Gorlich D.Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs.RNA. 2004;10:185-91
7. Lee Y,Jeon K,Lee JT,Kim S,Kim VN.MicroRNA maturation: stepwise processing and subcellular localization.EMBO J. 2002;21:4663-70
8. Bernstein E,Caudy AA,Hammond SM,Hannon GJ.Role for a bidentate ribonuclease in the initiation step of RNA interference.Nature. 2001;409:363-6
9. Grishok A,Pasquinelli AE,Conte D,Li N,Parrish S,Ha I,Baillie DL,Fire A,Ruvkun G,Mello CC.Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing.Cell. 2001;106:23-34
10. Hutvagner G,McLachlan J,Pasquinelli AE,Balint E,Tuschl T,Zamore PD.A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA.Science. 2001;293:834-8
11. Ketting RF,Fischer SE,Bernstein E,Sijen T,Hannon GJ,Plasterk RH.Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C.elegans. Genes Dev. 2001;15:2654-9
12. Knight SW,Bass BL.A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans.Science. 2001;293:2269-71
13. Bartel DP.MicroRNAs: target recognition and regulatory functions.Cell. 2009;136:215-33
14. Harfe BD.MicroRNAs in vertebrate development.Curr Opin Genet Dev. 2005;15:410-5
15. Bartel DP,Chen CZ.Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs.Nat Rev Genet. 2004;5:396-400
16. Rajewsky N.microRNA target predictions in animals.Nat Genet. 2006;38:S8-13
17. Lim LP,Lau NC,Garrett-Engele P,Grimson A,Schelter JM,Castle J,Bartel DP,Linsley PS,Johnson JM.Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.Nature. 2005;433:769-73
18. Valencia-Sanchez MA,Liu J,Hannon GJ,Parker R.Control of translation and mRNA degradation by miRNAs and siRNAs.Genes Dev. 2006;20:515-24
19. Esquela-Kerscher A,Slack FJ.Oncomirs – microRNAs with a role in cancer.Nat Rev Cancer. 2006;6:259-69
20. Jemal A,Bray F,Center MM,Ferlay J,Ward E,Forman D.Global cancer statistics.CA Cancer J Clin. 2011;61:69-90
21. Siegel R,Naishadham D,Jemal A.Cancer statistics, 2012.CA Cancer J Clin. 2012;62:10-29
22. Carbone DP.The biology of lung cancer.Semin Oncol. 1997;24:388-401
23. Brambilla E,Travis WD,Colby TV,Corrin B,Shimosato Y.The new World Health Organization classification of lung tumours.Eur Respir J. 2001;18:1059-68
24. Bryant A,Cerfolio RJ.Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.Chest. 2007;132:185-92
25. Subramanian J,Govindan R.Lung cancer in never smokers: a review.J Clin Oncol. 2007;25:561-70
26. Collins LG,Haines C,Perkel R,Enck RE.Lung cancer: diagnosis and management.Am Fam Physician. 2007;75:56-63
27. Carleton M,Cleary MA,Linsley PS.MicroRNAs and cell cycle regulation.Cell Cycle. 2007;6:2127-32.
28. Chivukula RR,Mendell JT.Circular reasoning: microRNAs and cell-cycle control.Trends Biochem Sci. 2008;33:474-81
29. Volinia S,Calin GA,Liu CG,Ambs S,Cimmino A,Petrocca F,Visone R,Iorio M,Roldo C,Ferracin M,Prueitt RL,Yanaihara N,Lanza G,Scarpa A,Vecchione A,Negrini M,Harris CC,Croce CM.A microRNA expression signature of human solid tumors defines cancer gene targets.Proc Natl Acad Sci U S A. 2006;103:2257-61
30. Bishop JM.Molecular themes in oncogenesis.Cell. 1991;64:235-48
31. Weinberg RA.Tumor suppressor genes.Science. 1991;254:1138-46
32. Calin GA,Sevignani C,Dumitru CD,Hyslop T,Noch E,Yendamuri S,Shimizu M,Rattan S,Bullrich F,Negrini M,Croce CM.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.Proc Natl Acad Sci U S A. 2004;101:2999-3004
33. Calin GA,Croce CM.MicroRNA signatures in human cancers.Nat Rev Cancer. 2006;6:857-66
34. McManus MT.MicroRNAs and cancer.Semin Cancer Biol. 2003;13:253-8
35. Gregory RI,Shiekhattar R.MicroRNA biogenesis and cancer.Cancer Res. 2005;65:3509-12
36. Croce CM,Calin GA.miRNAs, cancer, and stem cell division.Cell. 2005;122:6-7
37. Chen CZ.MicroRNAs as oncogenes and tumor suppressors.N Engl J Med. 2005;353:1768-71
38. Calin GA,Croce CM.MicroRNA-cancer connection: the beginning of a new tale.Cancer Res. 2006;66:7390-4
39. Croce CM.Causes and consequences of microRNA dysregulation in cancer.Nat Rev Genet. 2009;10:704-14
40. Bhaskaran M,Wang Y,Zhang H,Weng T,Baviskar P,Guo Y,Gou D,Liu L.MicroRNA-127 modulates fetal lung development.Physiol Genomics. 2009;37:268-78
41. Lize M,Herr C,Klimke A,Bals R,Dobbelstein M.MicroRNA-449a levels increase by several orders of magnitude during mucociliary differentiation of airway epithelia.Cell Cycle. 2010;9:4579-83
42. Boeri M,Verri C,Conte D,Roz L,Modena P,Facchinetti F,Calabro E,Croce CM,Pastorino U,Sozzi G.MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.Proc Natl Acad Sci U S A. 2011;108:3713-8
43. Yu SL,Chen HY,Chang GC,Chen CY,Chen HW,Singh S,Cheng CL,Yu CJ,Lee YC,Chen HS,Su TJ,Chiang CC,Li HN,Hong QS,Su HY,Chen CC,Chen WJ,Liu CC,Chan WK,Li KC,Chen JJ,Yang PC.MicroRNA signature predicts survival and relapse in lung cancer.Cancer Cell. 2008;13:48-57
44. Dong J,Jiang G,Asmann YW,Tomaszek S,Jen J,Kislinger T,Wigle DA.MicroRNA networks in mouse lung organogenesis.PLoS One. 2010;5:e10854-e10854
45. Williams AE,Moschos SA,Perry MM,Barnes PJ,Lindsay MA.Maternally imprinted microRNAs are differentially expressed during mouse and human lung development.Dev Dyn. 2007;236:572-80
46. Lu J,Qian J,Chen F,Tang X,Li C,Cardoso WV.Differential expression of components of the microRNA machinery during mouse organogenesis.Biochem Biophys Res Commun. 2005;334:319-23
47. Yanaihara N,Caplen N,Bowman E,Seike M,Kumamoto K,Yi M,Stephens RM,Okamoto A,Yokota J,Tanaka T,Calin GA,Liu CG,Croce CM,Harris CC.Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.Cancer Cell. 2006;9:189-98
48. Lujambio A,Ropero S,Ballestar E,Fraga MF,Cerrato C,Setien F,Casado S,Suarez-Gauthier A,Sanchez-Cespedes M,Git A,Spiteri I,Das PP,Caldas C,Miska E,Esteller M.Genetic unmasking of an epigenetically silenced microRNA in human cancer cells.Cancer Res. 2007;67:1424-9
49. Duan R,Pak C,Jin P.Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA.Hum Mol Genet. 2007;16:1124-31
50. Scott GK,Goga A,Bhaumik D,Berger CE,Sullivan CS,Benz CC.Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.J Biol Chem. 2007;282:1479-86
51. Hu Z,Chen J,Tian T,Zhou X,Gu H,Xu L,Zeng Y,Miao R,Jin G,Ma H,Chen Y,Shen H.Genetic variants of miRNA sequences and non-small cell lung cancer survival.J Clin Invest. 2008;118:2600-8
52. Yoon KA,Yoon H,Park S,Jang HJ,Zo JI,Lee HS,Lee JS.The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.J Thorac Cardiovasc Surg. 2012;144:794-807
53. Yu Z,Li Z,Jolicoeur N,Zhang L,Fortin Y,Wang E,Wu M,Shen SH.Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.Nucleic Acids Res. 2007;35:4535-41
54. Chin LJ,Ratner E,Leng S,Zhai R,Nallur S,Babar I,Muller RU,Straka E,Su L,Burki EA,Crowell RE,Patel R,Kulkarni T,Homer R,Zelterman D,Kidd KK,Zhu Y,Christiani DC,Belinsky SA,Slack FJ,Weidhaas JB.A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.Cancer Res. 2008;68:8535-40
55. Wang Z,Chen Z,Gao Y,Li N,Li B,Tan F,Tan X,Lu N,Sun Y,Sun J,Sun N,He J.DNA hypermethylation of microRNA-34b/c has prognostic value for stage non-small cell lung cancer.Cancer Biol Ther. 2011;11:490-6
56. Watanabe K,Emoto N,Hamano E,Sunohara M,Kawakami M,Kage H,Kitano K,Nakajima J,Goto A,Fukayama M,Nagase T,Yatomi Y,Ohishi N,Takai D.Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.Int J Cancer. 2012;130:2580-90
57. Tanaka N,Toyooka S,Soh J,Kubo T,Yamamoto H,Maki Y,Muraoka T,Shien K,Furukawa M,Ueno T,Asano H,Tsukuda K,Aoe K,Miyoshi S.Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.Lung Cancer. 2012;76:32-8
58. Heller G,Weinzierl M,Noll C,Babinsky V,Ziegler B,Altenberger C,Minichsdorfer C,Lang G,Dome B,End-Pfutzenreuter A,Arns BM,Grin Y,Klepetko W,Zielinski CC,Zochbauer-Muller S.Genome-wide miRNA expression profiling identifies miR-9-3 and miR‐193a as targets for DNA methylation in non-small cell lung cancers.Clin Cancer Res. 2012;18:1619-29
59. Incoronato M,Urso L,Portela A,Laukkanen MO,Soini Y,Quintavalle C,Keller S,Esteller M,Condorelli G.Epigenetic regulation of miR-212 expression in lung cancer.PLoS One. 2011;6:e27722-e27722
60. Fabbri M,Garzon R,Cimmino A,Liu Z,Zanesi N,Callegari E,Liu S,Alder H,Costinean S,Fernandez-Cymering C,Volinia S,Guler G,Morrison CD,Chan KK,Marcucci G,Calin GA,Huebner K,Croce CM.MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.Proc Natl Acad Sci U S A. 2007;104:15805-10
61. Nakagawa M,Oda Y,Eguchi T,Aishima S,Yao T,Hosoi F,Basaki Y,Ono M,Kuwano M,Tanaka M,Tsuneyoshi M.Expression profile of class I histone deacetylases in human cancer tissues.Oncol Rep. 2007;18:769-74
62. Krusche CA,Wulfing P,Kersting C,Vloet A,Bocker W,Kiesel L,Beier HM,Alfer J.Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis.Breast Cancer Res Treat. 2005;90:15-23
63. Fritzsche FR,Weichert W,Roske A,Gekeler V,Beckers T,Stephan C,Jung K,Scholman K,Denkert C,Dietel M,Kristiansen G.Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer.BMC Cancer. 2008;8:381-381
64. Weichert W,Roske A,Gekeler V,Beckers T,Ebert MP,Pross M,Dietel M,Denkert C,Rocken C.Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.Lancet Oncol. 2008;9:139-48
65. Weichert W,Roske A,Niesporek S,Noske A,Buckendahl AC,Dietel M,Gekeler V,Boehm M,Beckers T,Denkert C.Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.Clin Cancer Res. 2008;14:1669-77
66. Jeon HS,Lee SY,Lee EJ,Yun SC,Cha EJ,Choi E,Na MJ,Park JY,Kang J,Son JW.Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer.Lung Cancer. 2012;76:171-6
67. Hayashita Y,Osada H,Tatematsu Y,Yamada H,Yanagisawa K,Tomida S,Yatabe Y,Kawahara K,Sekido Y,Takahashi T.A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.Cancer Res. 2005;65:9628-32
68. O'Donnell KA,Wentzel EA,Zeller KI,Dang CV,Mendell JT.c-Myc-regulated microRNAs modulate E2F1 expression.Nature. 2005;435:839-43
69. Tagawa H,Karube K,Tsuzuki S,Ohshima K,Seto M.Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.Cancer Sci. 2007;98:1482-90
70. Dews M,Homayouni A,Yu D,Murphy D,Sevignani C,Wentzel E,Furth EE,Lee WM,Enders GH,Mendell JT,Thomas-Tikhonenko A.Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.Nat Genet. 2006;38:1060-5
71. Lewis BP,Shih IH,Jones-Rhoades MW,Bartel DP,Burge CB.Prediction of mammalian microRNA targets.Cell. 2003;115:787-98
72. Wang Q,Li YC,Wang J,Kong J,Qi Y,Quigg RJ,Li X.miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130.Proc Natl Acad Sci U S A. 2008;105:2889-94
73. Zhu S,Wu H,Wu F,Nie D,Sheng S,Mo YY.MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.Cell Res. 2008;18:350-9
74. Markou A,Tsaroucha EG,Kaklamanis L,Fotinou M,Georgoulias V,Lianidou ES.Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.Clin Chem. 2008;54:1696-704
75. Lu Z,Liu M,Stribinskis V,Klinge CM,Ramos KS,Colburn NH,Li Y.MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene.Oncogene. 2008;27:4373-9
76. Gabriely G,Wurdinger T,Kesari S,Esau CC,Burchard J,Linsley PS,Krichevsky AM.MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.Mol Cell Biol. 2008;28:5369-80
77. Frankel LB,Christoffersen NR,Jacobsen A,Lindow M,Krogh A,Lund AH.Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.J Biol Chem. 2008;283:1026-33
78. Zhu S,Si ML,Wu H,Mo YY.MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).J Biol Chem. 2007;282:14328-36
79. Yeung ML,Yasunaga J,Bennasser Y,Dusetti N,Harris D,Ahmad N,Matsuoka M,Jeang KT.Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1.Cancer Res. 2008;68:8976-85
80. Weiss GJ,Bemis LT,Nakajima E,Sugita M,Birks DK,Robinson WA,Varella-Garcia M,Bunn PA,Haney J,Helfrich BA,Kato H,Hirsch FR,Franklin WA.EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.Ann Oncol. 2008;19:1053-9
81. Johnson SM,Grosshans H,Shingara J,Byrom M,Jarvis R,Cheng A,Labourier E,Reinert KL,Brown D,Slack FJ.RAS is regulated by the let-7 microRNA family.Cell. 2005;120:635-47
82. Roush S,Slack FJ.The let-7 family of microRNAs.Trends Cell Biol. 2008;18:505-16
83. Sarhadi VK,Wikman H,Salmenkivi K,Kuosma E,Sioris T,Salo J,Karjalainen A,Knuutila S,Anttila S.Increased expression of high mobility group A proteins in lung cancer.J Pathol. 2006;209:206-12
84. Motoyama K,Inoue H,Nakamura Y,Uetake H,Sugihara K,Mori M.Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.Clin Cancer Res. 2008;14:2334-40
85. Lee YS,Dutta A.The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.Genes Dev. 2007;21:1025-30
86. Calin GA,Dumitru CD,Shimizu M,Bichi R,Zupo S,Noch E,Aldler H,Rattan S,Keating M,Rai K,Rassenti L,Kipps T,Negrini M,Bullrich F,Croce CM.Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.Proc Natl Acad Sci U S A. 2002;99:15524-9
87. Cimmino A,Calin GA,Fabbri M,Iorio MV,Ferracin M,Shimizu M,Wojcik SE,Aqeilan RI,Zupo S,Dono M,Rassenti L,Alder H,Volinia S,Liu CG,Kipps TJ,Negrini M,Croce CM.miR-15 and miR-16 induce apoptosis by targeting BCL2.Proc Natl Acad Sci U S A. 2005;102:13944-9
88. Calin GA,Cimmino A,Fabbri M,Ferracin M,Wojcik SE,Shimizu M,Taccioli C,Zanesi N,Garzon R,Aqeilan RI,Alder H,Volinia S,Rassenti L,Liu X,Liu CG,Kipps TJ,Negrini M,Croce CM.MiR-15a and miR-16-1 cluster functions in human leukemia.Proc Natl Acad Sci U S A. 2008;105:5166-71
89. Sander S,Bullinger L,Klapproth K,Fiedler K,Kestler HA,Barth TF,Moller P,Stilgenbauer S,Pollack JR,Wirth T.MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.Blood. 2008;112:4202-12
90. Mott JL,Kobayashi S,Bronk SF,Gores GJ.mir-29 regulates Mcl-1 protein expression and apoptosis.Oncogene. 2007;26:6133-40
91. Zhao JJ,Lin J,Lwin T,Yang H,Guo J,Kong W,Dessureault S,Moscinski LC,Rezania D,Dalton WS,Sotomayor E,Tao J,Cheng JQ.microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.Blood. 2010;115:2630-9
92. Cittelly DM,Finlay-Schultz J,Howe EN,Spoelstra NS,Axlund SD,Hendricks P,Jacobsen BM,Sartorius CA,Richer JK.Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.Oncogene. 2013;32:2555-64
93. Rice SJ,Lai SC,Wood LW,Helsley KR,Runkle EA,Winslow MM,Mu D.MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1).J Biol Chem. 2013;288:16348-60
94. Tavazoie SF,Alarcon C,Oskarsson T,Padua D,Wang Q,Bos PD,Gerald WL,Massague J.Endogenous human microRNAs that suppress breast cancer metastasis.Nature. 2008;451:147-52
95. Musiyenko A,Bitko V,Barik S.Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells.J Mol Med (Berl). 2008;86:313-22
96. Crawford M,Brawner E,Batte K,Yu L,Hunter MG,Otterson GA,Nuovo G,Marsh CB,Nana-Sinkam SP.MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.Biochem Biophys Res Commun. 2008;373:607-12
97. Harris TA,Yamakuchi M,Ferlito M,Mendell JT,Lowenstein CJ.MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1.Proc Natl Acad Sci U S A. 2008;105:1516-21
98. Duursma AM,Kedde M,Schrier M,le Sage C,Agami R.miR-148 targets human DNMT3b protein coding region.RNA. 2008;14:872-7
99. Kang SM,Lee HJ,Cho JY.MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer.Cancer Lett. 2013;335:487-94
100. Qi J,Rice SJ,Salzberg AC,Runkle EA,Liao J,Zander DS,Mu D.MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1.Cell Cycle. 2012;11:177-86
101. Chan JA,Krichevsky AM,Kosik KS.MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.Cancer Res. 2005;65:6029-33
102. Slaby O,Svoboda M,Fabian P,Smerdova T,Knoflickova D,Bednarikova M,Nenutil R,Vyzula R.Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.Oncology. 2007;72:397-402
103. Iorio MV,Ferracin M,Liu CG,Veronese A,Spizzo R,Sabbioni S,Magri E,Pedriali M,Fabbri M,Campiglio M,Menard S,Palazzo JP,Rosenberg A,Musiani P,Volinia S,Nenci I,Calin GA,Querzoli P,Negrini M,Croce CM.MicroRNA gene expression deregulation in human breast cancer.Cancer Res. 2005;65:7065-70
104. Sempere LF,Christensen M,Silahtaroglu A,Bak M,Heath CV,Schwartz G,Wells W,Kauppinen S,Cole CN.Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.Cancer Res. 2007;67:11612-20
105. Kumar MS,Erkeland SJ,Pester RE,Chen CY,Ebert MS,Sharp PA,Jacks T.Suppression of non-small cell lung tumor development by the let-7 microRNA family.Proc Natl Acad Sci U S A. 2008;105:3903-8
106. Yu F,Yao H,Zhu P,Zhang X,Pan Q,Gong C,Huang Y,Hu X,Su F,Lieberman J,Song E.let-7 regulates self renewal and tumorigenicity of breast cancer cells.Cell. 2007;131:1109-23
107. Kendall J,Liu Q,Bakleh A,Krasnitz A,Nguyen KC,Lakshmi B,Gerald WL,Powers S,Mu D.Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer.Proc Natl Acad Sci U S A. 2007;104:16663-8
108. Kwei KA,Kim YH,Girard L,Kao J,Pacyna-Gengelbach M,Salari K,Lee J,Choi YL,Sato M,Wang P,Hernandez-Boussard T,Gazdar AF,Petersen I,Minna JD,Pollack JR.Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.Oncogene. 2008;27:3635-40
109. Perner S,Wagner PL,Soltermann A,LaFargue C,Tischler V,Weir BA,Weder W,Meyerson M,Giordano TJ,Moch H,Rubin MA.TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.J Pathol. 2009;217:65-72
110. Boggaram V.Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) gene regulation in the lung.Clin Sci (Lond). 2009;116:27-35
111. Yatabe Y,Mitsudomi T,Takahashi T.TTF-1 expression in pulmonary adenocarcinomas.Am J Surg Pathol. 2002;26:767-73
112. Henschke CI,McCauley DI,Yankelevitz DF,Naidich DP,McGuinness G,Miettinen OS,Libby DM,Pasmantier MW,Koizumi J,Altorki NK,Smith JP.Early lung cancer action project: overall design and findings from baseline screening.Lancet. 1999;354:99-105
113. Priola AM,Priola SM,Giaj-Levra M,Basso E,Veltri A,Fava C,Cardinale L.Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed tomography.Clin Lung Cancer. 2013;14:139-48
114. Dalton WS,Friend SH.Cancer biomarkers–an invitation to the table.Science. 2006;312:1165-8
115. Friedlander MR,Chen W,Adamidi C,Maaskola J,Einspanier R,Knespel S,Rajewsky N.Discovering microRNAs from deep sequencing data using miRDeep.Nat Biotechnol. 2008;26:407-15
116. Metzker ML.Sequencing technologies – the next generation.Nat Rev Genet. 2010;11:31-46
117. Lu C,Shedge V.Construction of small RNA cDNA libraries for high-throughput sequencing.Methods Mol Biol. 2011;729:141-52
118. Rosenfeld N,Aharonov R,Meiri E,Rosenwald S,Spector Y,Zepeniuk M,Benjamin H,Shabes N,Tabak S,Levy A,Lebanony D,Goren Y,Silberschein E,Targan N,Ben-Ari A,Gilad S,Sion-Vardy N,Tobar A,Feinmesser M,Kharenko O,Nativ O,Nass D,Perelman M,Yosepovich A,Shalmon B,Polak-Charcon S,Fridman E,Avniel A,Bentwich I,Bentwich Z,Cohen D,Chajut A,Barshack I.MicroRNAs accurately identify cancer tissue origin.Nat Biotechnol. 2008;26:462-9
119. Lu J,Getz G,Miska EA,Alvarez-Saavedra E,Lamb J,Peck D,Sweet-Cordero A,Ebert BL,Mak RH,Ferrando AA,Downing JR,Jacks T,Horvitz HR,Golub TR.MicroRNA expression profiles classify human cancers.Nature. 2005;435:834-8
120. Takamizawa J,Konishi H,Yanagisawa K,Tomida S,Osada H,Endoh H,Harano T,Yatabe Y,Nagino M,Nimura Y,Mitsudomi T,Takahashi T.Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.Cancer Res. 2004;64:3753-6
121. Baskerville S,Bartel DP.Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes.RNA. 2005;11:241-7
122. Farh KK,Grimson A,Jan C,Lewis BP,Johnston WK,Lim LP,Burge CB,Bartel DP.The widespread impact of mammalian MicroRNAs on mRNA repression and evolution.Science. 2005;310:1817-21
123. Landgraf P,Rusu M,Sheridan R,Sewer A,Iovino N,Aravin A,Pfeffer S,Rice A,Kamphorst AO,Landthaler M,Lin C,Socci ND,Hermida L,Fulci V,Chiaretti S,Foa R,Schliwka J,Fuchs U,Novosel A,Muller RU,Schermer B,Bissels U,Inman J,Phan Q,Chien M,Weir DB,Choksi R,De Vita G,Frezzetti D,Trompeter HI,Hornung V,Teng G,Hartmann G,Palkovits M,Di Lauro R,Wernet P,Macino G,Rogler CE,Nagle JW,Ju J,Papavasiliou FN,Benzing T,Lichter P,Tam W,Brownstein MJ,Bosio A,Borkhardt A,Russo JJ,Sander C,Zavolan M,Tuschl T.A mammalian microRNA expression atlas based on small RNA library sequencing.Cell. 2007;129:1401-14
124. Mitchell PS,Parkin RK,Kroh EM,Fritz BR,Wyman SK,Pogosova-Agadjanyan EL,Peterson A,Noteboom J,O'Briant KC,Allen A,Lin DW,Urban N,Drescher CW,Knudsen BS,Stirewalt DL,Gentleman R,Vessella RL,Nelson PS,Martin DB,Tewari M.Circulating microRNAs as stable blood-based markers for cancer detection.Proc Natl Acad Sci U S A. 2008;105:10513-8
125. Chen X,Ba Y,Ma L,Cai X,Yin Y,Wang K,Guo J,Zhang Y,Chen J,Guo X,Li Q,Li X,Wang W,Wang J,Jiang X,Xiang Y,Xu C,Zheng P,Zhang J,Li R,Zhang H,Shang X,Gong T,Ning G,Zen K,Zhang CY.Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.Cell Res. 2008;18:997-1006
126. Gilad S,Meiri E,Yogev Y,Benjamin S,Lebanony D,Yerushalmi N,Benjamin H,Kushnir M,Cholakh H,Melamed N,Bentwich Z,Hod M,Goren Y,Chajut A.Serum microRNAs are promising novel biomarkers.PLoS One. 2008;3:e3148-e3148